Searle’s Denosumab biosimilar gains regulatory approval

MG News | September 10, 2025 at 01:08 PM GMT+05:00

0:00

September 10, 2025 (MLN): Searle Company Limited has reached a major milestone as Denosumab, Pakistan’s first biosimilar of its kind, receives regulatory approval.

This development marked a transformative moment in the country’s pharmaceutical sector as it introduced a locally developed biotechnological therapy that expands access and affordability for patients nationwide.

Denosumab, a monoclonal antibody used to treat osteoporosis and cancer-related bone conditions, now enters the market in biosimilar form, offering a cost-effective alternative to imported treatments.

Patients previously burdened by high prices may now benefit from the broader availability of this advanced therapy.

“This approval reflects a commitment to innovation and patient-focused healthcare,” the company stated. “It signals progress toward greater accessibility and long-term value creation.”

It will potentially reshape the biotech landscape and encourage investment in local research and manufacturing.

Copyright Mettis Link News

Related News

NDMA dispatches 20 more relief trucks to Punjab

Digital transformation key to Pakistan’s industrial future

Name	Price/Vol	%Chg/NChg
KSE100	157,020.80 437.13M	0.29% 457.27
ALLSHR	95,556.69 993.87M	0.37% 353.92
KSE30	48,080.41 125.69M	0.18% 84.28
KMI30	230,750.57 158.39M	0.35% 810.80
KMIALLSHR	64,377.44 554.03M	0.47% 301.82
BKTi	42,342.54 83.25M	-0.34% -143.15
OGTi	32,369.84 35.81M	0.82% 263.37

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	114,065.00	114,335.00 111,230.00	2370.00 2.12%
BRENT CRUDE	66.93	67.23 66.66	0.54 0.81%
RICHARDS BAY COAL MONTHLY	85.00	86.00 85.00	-1.60 -1.85%
ROTTERDAM COAL MONTHLY	93.05	94.00 93.05	-1.15 -1.22%
USD RBD PALM OLEIN	1,106.50	1,106.50 1,106.50	0.00 0.00%
CRUDE OIL - WTI	63.13	63.49 62.72	0.50 0.80%
SUGAR #11 WORLD	15.86	15.95 15.70	0.02 0.13%